bumetanide has been researched along with Chronic Disease in 7 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| " bumetanide (25 micrograms kg-1) were prospectively studied in 24 patients with angiographically documented coronary artery disease and either acute exercise-induced (Group I, n = 12) or chronic (Group II, n = 12) heart failure." | 9.06 | Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure. ( Frais, MA; Muller, P; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1987) |
| " bumetanide (25 micrograms kg-1) were prospectively studied in 24 patients with angiographically documented coronary artery disease and either acute exercise-induced (Group I, n = 12) or chronic (Group II, n = 12) heart failure." | 5.06 | Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure. ( Frais, MA; Muller, P; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1987) |
| "Neuropathic pain is a common problem following spinal cord injury (SCI)." | 1.36 | Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. ( Ahmed, MM; Hasbargen, T; Kahle, KT; Li, L; Miranpuri, G; Resnick, D; Sun, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacKenzie, G | 1 |
| Maguire, J | 1 |
| De Smedt, RH | 1 |
| Jaarsma, T | 1 |
| van den Broek, SA | 1 |
| Haaijer-Ruskamp, FM | 1 |
| Hasbargen, T | 1 |
| Ahmed, MM | 1 |
| Miranpuri, G | 1 |
| Li, L | 1 |
| Kahle, KT | 1 |
| Resnick, D | 1 |
| Sun, D | 1 |
| Jin, X | 1 |
| Huguenard, JR | 1 |
| Prince, DA | 1 |
| Kubik, MM | 1 |
| Bowers, E | 1 |
| Underwood, PN | 1 |
| Seth, HC | 1 |
| Coulshed, N | 1 |
| Epstein, E | 1 |
| Verma, SP | 1 |
| Silke, B | 1 |
| Reynolds, G | 1 |
| Muller, P | 1 |
| Frais, MA | 1 |
| Taylor, SH | 1 |
3 trials available for bumetanide and Chronic Disease
| Article | Year |
|---|---|
Comparison of separate versus simultaneous administration of potassium supplement with the diuretic bumetanide.
Topics: Aged; Bicarbonates; Bumetanide; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; H | 1977 |
Intravenous bumetanide in the treatment of acute and chronic pulmonary oedema.
Topics: Acute Disease; Bumetanide; Chronic Disease; Clinical Trials as Topic; Diuretics; Female; Humans; Inj | 1975 |
Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure.
Topics: Acute Disease; Adult; Aged; Bumetanide; Chronic Disease; Clinical Trials as Topic; Diuretics; Electr | 1987 |
4 other studies available for bumetanide and Chronic Disease
| Article | Year |
|---|---|
Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility.
Topics: Acute Disease; Animals; Bumetanide; Chronic Disease; Corticosterone; Disease Models, Animal; gamma-A | 2015 |
Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report.
Topics: Aged; Anticonvulsants; Bumetanide; Chronic Disease; gamma-Aminobutyric Acid; Heart Failure; Herpes Z | 2008 |
Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury.
Topics: Animals; Bumetanide; Chronic Disease; gamma-Aminobutyric Acid; Hyperalgesia; Inflammation; K Cl- Cot | 2010 |
Impaired Cl- extrusion in layer V pyramidal neurons of chronically injured epileptogenic neocortex.
Topics: Animals; Bumetanide; Chlorides; Chronic Disease; Epilepsy; K Cl- Cotransporters; Membrane Potentials | 2005 |